Day 1 – 28th September
CESPE Industry-Focused Session (Morning)
Theme: “PAT in Practice: Implementation Challenges, Measurable Impact and Real Outcomes”
09:00 – 09:10 Opening speech by Willem Dhooge
Platform Manager at CESPE
Talk title to be announced

09:10 – 09:35 Talk by Jakob Christensen
PAT Implementation Lead at Novo Nordisk Engineering
Title: ‘PAT in Full Scale Biomanufacturing – Implementation Experience and Challenges’

09:35 – 10:00 Talk by Yannick Borguet
MSAT Laboratory Lead at Takeda
Talk title to be announced

10:00 – 10:25 Talk by Melanie Dumarey
Product and Process Design Engineer at AstraZeneca
Title: ‘A leading role for PAT in continuous manufacturing’

10:25 – 10:50 Talk by Laurent Strodiot
Director at R&D and DP Department at GSK
Title: ”PAT strategy to master continuous process – example for on-line vaccine formulation”

10:50 – 11:20 Coffee Break
11:20 – 11:45 Talk by Shana Van de Steene
Application Specialist Continuous Manufacturing at
Fette Compacting
Talk title to be announced

11:45 – 12:10 Talk by Olivier Van Der Ha
Research Project Manager for Continuous Improvement at Ajinomoto OmniChem
Talk title to be announced

12:10 – 12:35 Talk by Jeroen Hofenk
Founder & CSO at SwiftPharma
Talk title to be announced

12:35 – 13:30 Lunch Break
13:30 – 16:30 EuPAT/CESPE Hands-on Workshops (more details to be announced soon!)
16:30 – 18:30 Afternoon Reception
Day 2 – 29th September
EuPAT 1st Session (Morning)
Theme: ‘Next-Generation Sensors, Advanced PAT Tools and Innovative QbD Strategies‘
Keynote Lecture by Prof. Dr. Axel Zeitler from University of Cambridge, UK
Title: ‘Terahertz Porosity Sensing for Disintegration Prediction’
Keynote Lecture by Dr. Tom Van den Kerkhof from Johnson & Johnson Innovative Medicine, BE
Title: ‘Control Strategies and Real-Time Release for Continuous Manufacturing: Case Studies’
Keynote Lecture by Jan-Sebastiaan Uyttersprot from Union Chimique Belge, BE
Title: ‘From PAT Signals to Process Decisions: Designing Closed-Loop Controls for Drug Substance Biopharma Manufacturing’
EuPAT 2nd Session (Afternoon)
Theme: ‘Integrated and Autonomous
Pharmaceutical Platforms‘
Keynote Lecture by Prof. Dr. Ossi Korhonen from University of Eastern Finland, FI
Title: ‘Continuous Direct Compression in Development of Dispersible Combination Tablet for HIV-positive Pediatric Patients’
Keynote Lecture by Dr. Jérôme Mantanus & Dr. Efty Hadjittofis from Union Chimique Belge, BE
Title: ‘Particle Engineering as an Enabler for Continuous Flow Processing’
Day 3 – 30th September
EuPAT 3rd Session (Morning)
Theme: ‘Artificial Intelligence across the Pharmaceutical Lifecycle‘
Keynote lecture by Dr. Silvia Vogl from European Medicines Agency, Quality Innovation Group
Title: ‘The EU Quality Innovation Group Perspective on Modelling and AI in Pharmaceutical Process Development and Manufacturing’
Keynote Lecture by Prof. Dr. Daniel Markl from University of Strathclyde, GB
Title: ‘From Material, Process, and Product Knowledge to the AI Formulator’
Keynote Lecture by Prof. Dr. Kārlis Bērziņš from University of Copenhagen, DK
Title: ‘Predictive Pharmaceutical Development and Process Intelligence through Low-Frequency Vibrational Spectroscopy’

